Decoding the transcriptome
A platform for drug discovery in RNA biology
Scaffold Therapeutics is advancing a unique pipeline of assets targeting clinically validated and first in class biology in oncology, neurodegeneration and other therapeutic areas
Our research is focused on regulating modifications of RNA that control its stability, transcription and degradation.
Now partnered with QureALZ!
Scaffold Therapeutics has partnered with QureALZ - a company dedicated to sponsoring breakthrough research on Alzheimer's and other neurodegenerative disorders. This partnership will leverage Scaffold's drug discovery platform and world class drug discovery team to advance research into a range of diseases from Alzheimer's disease to ALS to brain cancer.